Supported by an independent educational grant from Astellas

Access Dermatology

  • Advisory Board
  • About Us
  • Contact Us
  • Subscribe to our RSS Feed
  • Breaking News
  • Clinical Trials
  • Congress Reports
  • Clinical Cases
  • Core Papers
  • Expert Interviews
  • Editorial Blog
  • Who's Who
  • Centre of Learning Excellence
  • Image Bank
  • Professional Development
  • Calendar
  • Useful Links
Thomson Reuters

Breaking News

  • Home »
  • Breaking News
 
18 November 2010
Similar outcomes with ipilimumab regardless of HLA status in retrospective analysis of patients with advanced melanoma
 
 
1

Last updated: 19 November 2010

AccessDermatology  | © Copyright 2010 Prous Science S.A.U. a Thomson Reuters business or its licensors. All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.